Roschier represented EQT and Recipharm in the carve-out of seven of Recipharm’s CDMO sites in Sweden, Spain and France

Recent work|April 10, 2024

Roschier represented EQT and Recipharm in selling seven CDMO sites in Sweden, Spain, and France to Blue Wolf Capital, an US private equity firm.

Roschier represented EQT, a leading Nordic investment organisation, and Recipharm, a global CDMO operator, in the divestment of seven of Recipharm’s CDMO sites in Sweden, Spain and France, to Blue Wolf Capital, an American private equity firm investing in buyouts, recapitalization and growth capital opportunities.

Roschier’s core advisory team comprised Jens Bengtsson, Leo Lee, Sara Hill, Carl Byström, Björn Johansson Heigis, John Park, and Jenny Welander Wadström.